Humanigen Inc (HGENQ)

[DonDonDonDon]

Second, the observations pertaining to benefits in the population that had CRP<150 mg/L and age <85 were exploratory.

Both of those results could have been predicted. We already knew that treating the cytokine storm right when it is beginning would be best. And we knew 85+ year olds have good immune systems and don't experience the cytokine storm much.

3 fold efficacy is awesome. FDA guidance will be to use lenzilumab right when a patient becomes severe. 85+ year olds might be excluded or it could be at the discretion of the doctor.